BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28798482)

  • 1. Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).
    Shibutani S; Okazaki H; Iwata H
    J Biol Chem; 2017 Nov; 292(44):18052-18061. PubMed ID: 28808055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-microRNA signature predicts the progression of male thyroid cancer.
    Liu B; Shi H; Qiu W; Wu X; Li L; Wu W
    Open Life Sci; 2021; 16(1):981-991. PubMed ID: 34595349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B16 Melanoma Cancer Cells with Higher Metastatic Potential are More Deformable at a Whole-Cell Level.
    Ujihara Y; Ono D; Nishitsuji K; Ito M; Sugita S; Nakamura M
    Cell Mol Bioeng; 2021 Aug; 14(4):309-320. PubMed ID: 34295442
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ombid RJL; Oyong GG; Cabrera EC; Espulgar WV; Saito M; Tamiya E; Pobre RF
    Biomed Opt Express; 2020 Oct; 11(10):6027-6037. PubMed ID: 33150003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical operations on a living single cell by open microfluidics for wound repair studies and organelle transport analysis.
    Mao S; Zhang Q; Liu W; Huang Q; Khan M; Zhang W; Lin C; Uchiyama K; Lin JM
    Chem Sci; 2019 Feb; 10(7):2081-2087. PubMed ID: 30881632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a microfluidic platform for size-based hydrodynamic enrichment and PSMA-targeted immunomagnetic isolation of circulating tumour cells in prostate cancer.
    Esmaeilsabzali H; Payer RTM; Guo Y; Cox ME; Parameswaran AM; Beischlag TV; Park EJ
    Biomicrofluidics; 2019 Jan; 13(1):014110. PubMed ID: 30867880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
    Araki K; Miyoshi Y
    Breast Cancer; 2018 Jul; 25(4):392-401. PubMed ID: 29086897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.
    Khakshour S; Labrecque MP; Esmaeilsabzali H; Lee FJS; Cox ME; Park EJ; Beischlag TV
    Sci Rep; 2017 Aug; 7(1):7833. PubMed ID: 28798482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
    Xing L; Zhang L; Feng Y; Cui Z; Ding L
    Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
    Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
    Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypoxia-induced fibronectin-integrin β1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK.
    Lee SH; Lee YJ; Han HJ
    J Cell Physiol; 2011 Feb; 226(2):484-93. PubMed ID: 20677223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
    Labrecque MP; Takhar MK; Nason R; Santacruz S; Tam KJ; Massah S; Haegert A; Bell RH; Altamirano-Dimas M; Collins CC; Lee FJ; Prefontaine GG; Cox ME; Beischlag TV
    Oncotarget; 2016 Apr; 7(17):24284-302. PubMed ID: 27015368
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.